得气强度与脑网络调制的剂量-反应曲线:从主观感觉走向可量化的中介效应

Written by

in

Language

Evidence level: B

得气不是”玄学体验”,而是一个可分级、可测量的刺激强度阈值——问题不在”有没有得气”,而在”得气多强才能调制多大的脑网络,而这又是否真的决定了疗效”。

正文

“得气”是针灸理论中最核心也最模糊的概念。传统说法里,得气是针刺时患者感到的酸、麻、胀、重等复合感觉,也是医者手下”针下沉紧”的触感,被视为取效的前提。但把它交给科学时,第一个困难就来了:得气是主观的,怎么量化?第二个困难更大:即便能量化,得气强度与疗效之间到底是什么关系——是”越强越好”的线性剂量-反应,还是达到阈值后平台期,还是干脆无关?

第一步:得气可以被量化

好消息是,得气早已不是玄学。多项研究证明它可以用标准化量表稳定测量。PMID 17973984 在一项 42 名针刺初学者的 RCT 中,用问卷系统刻画了得气的组成:酸、麻、胀、重是最常见的感觉,针刺诱发得气的频率(71%)和强度显著高于非侵入性触觉刺激(24%),并据此提出”得气复合”(deqi composite)作为概括不同穴位得气差异的指标。而 PMID 23935656 在膝骨关节炎患者的长程试验中验证了 MGH 针刺感觉量表(MASS)的可靠性:11/12 项感觉的评定者内信度(ICC)达标,”沉重感”最稳定。得气测量工具的可信度,已经够撑起一个实验了。

第二步:得气对应着可观测的身体与脑改变

得气不仅有主观量表,还对应着可测量的生理信号。PMID 25228908 直接提出:得气本质上是刺激强度的阈值——针刺诱发得气后,穴位局部血流灌注、组织位移、肌电幅度都显著上升,同时 fMRI 显示多个脑区信号增减。也就是说,”得气与否”这一主观判断,对应着客观可测的穴位与脑响应切换。PMID 27062952 进一步展示了强度分级的神经基础:BL40 穴浅刺(2mm,几乎无得气)与深刺(10-20mm,14/16 人复合得气)诱发的静息态脑网络改变完全不同——深刺得气降低默认模式网络(DMN)与疼痛矩阵网络的连接、增强小脑右后叶、海马旁回、丘脑与辅助运动区连接。得气从”有没有”到”多强”,在脑网络上是有刻度的。

第三步:刺激强度确实存在剂量-反应——但方向复杂

如果把”剂量”操作化为刺激强度,证据方向是清楚的:更强的刺激产生更强的调制。PMID 31088511 是一项 301 名膝骨关节炎患者的多中心三臂 RCT:强电针(>2mA)在缓解疼痛和改善条件性疼痛调制(CPM)方面显著优于弱电针(<0.5mA)和假电针,强电针改善 CPM 比弱电针多出 9.73 分(p<0.01)。PMID 16527396 在健康人的双盲 RCT 中同样发现,高强度(至耐受但非伤害性)电针显著提高压痛阈值,而低强度(强但舒适)与安慰剂无差异。这些说明”刺激强度→生理/临床响应”确实存在单调剂量-反应。

第四步:但”主观得气强度→疗效”的证据是分裂的

关键反转来了:当把”剂量”操作化为患者报告的主观得气强度时,剂量-反应关系就崩了。PMID 20964256 分析了 147 名骨关节炎患者的 RCT 数据:得气强度与疼痛缓解无显著相关(p=0.49),得气与否的患者在疗效上也无差异(p=0.52)——这是得气与疗效关系中最著名的阴性结果。PMID 31223331 则给出部分阳性:在原发性痛经患者中,得气感觉的强度、成分与扩散确实影响 SP6 穴的即刻镇痛效果。两篇文献一阴一阳,正是争议所在。

第五步:缺的那块拼图——中介效应

为什么刺激强度有剂量-反应、主观得气却没有?最可能的原因:得气与疗效之间隔着一层”脑网络调制”,而这层中介从未被系统检验过。PMID 24280949 显示,慢性腰痛患者针刺 4 周后 DMN 连接异常被逆转,且 DMN 连接的恢复与疼痛缓解显著相关。PMID 41520025(2026,纤维肌痛 RCT 中介分析)更是直接做了中介检验:电针通过增强初级躯体感觉皮层激活及 S1-岛叶连接(”自下而上”通路)中介广泛疼痛的缓解,而假激光走的是另一条”自上而下”通路。这证明”脑网络调制中介疗效”的方法学已经跑通——但还没有人把”得气强度→脑网络调制幅度→临床疗效”放进同一条剂量-反应与中介链里一起测。

这正是本文要指出的实证空白:三项独立的证据各自成立(得气可量化、得气对应脑网络改变、脑网络调制中介疗效),但连接它们的完整因果链从未被测量。

证据与局限

已验证: 得气可被标准化量表稳定测量(PMID 17973984, 23935656);得气对应穴位血流/肌电/脑 fMRI 改变,深刺得气显著改变 DMN 连接(PMID 25228908, 27062952);电针刺激强度存在明确剂量-反应(PMID 31088511, 16527396);针刺诱导的脑网络改变与临床疼痛缓解相关,脑网络调制可中介疗效(PMID 24280949, 41520025)。

部分验证: 主观得气强度与疗效的关系存在矛盾结果——骨关节炎 RCT 阴性(PMID 20964256)vs 痛经 RCT 阳性(PMID 31223331),提示可能受疾病类型、穴位、量表差异影响。

待验证: “得气强度分级→脑网络调制幅度→临床疗效”的完整剂量-反应曲线与中介效应(Sobel/自助法中介检验)从未在同一纵向疗程中被测量;得气量表主观分是否与刺激强度客观分重合,也缺乏头对头验证。

相关阅读

证据等级: B(得气量化、强度剂量-反应、脑网络中介疗效均有 PubMed 直接支撑,但”得气强度→网络调制幅度→疗效”的完整中介链本身无先例,属研究设计提案)
参考文献: PMID 25228908, PMID 27062952, PMID 17973984, PMID 23935656, PMID 20964256, PMID 31223331, PMID 31088511, PMID 16527396, PMID 41520025, PMID 24280949


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Dose-Response Curve of Acupoint Sensation Intensity and Brain Network Modulation: From Subjective Perception to Quantifiable Mediating Effects

Evidence level: B

Deqi is not an “esoteric-tradition experience” but a graded, measurable threshold of stimulus intensity. The question is not whether Deqi occurs, but rather “how strong must the Deqi be to modulate brain networks of sufficient magnitude, and does this modulation truly determine therapeutic efficacy?”

Main Text

Deqi is the most central yet ambiguous concept in acupuncture theory. Traditionally, Deqi refers to the composite sensations of soreness, numbness, distension, and heaviness felt by the patient during needle insertion, as well as the tactile sensation of “needle sinking and tightness” perceived by the practitioner, viewed as a prerequisite for efficacy. However, when subjected to scientific inquiry, two primary challenges arise: first, Deqi is subjective; how can it be quantified? Second, even if quantified, what is the relationship between Deqi intensity and therapeutic outcomes—is it a linear dose-response where “stronger is better,” does it plateau after a threshold, or is it irrelevant?

Step 1: Deqi Can Be Quantified

Good news is that Deqi is no longer considered esoteric. Multiple studies demonstrate its stable measurement via standardized scales. PMID 17973984 utilized a questionnaire system in an RCT involving 42 novice acupuncturists to characterize the composition of Deqi: soreness, numbness, distension, and heaviness were the most common sensations. The frequency (71%) and intensity of Deqi induced by needle insertion were significantly higher than non-invasive tactile stimuli (24%), leading to the proposal of a “Deqi Composite” as an indicator summarizing variations in Deqi across different acupoints. Meanwhile, PMID 23935656 validated the reliability of the Modified McGill Acupuncture Sensation Scale (MASS) in a long-term trial with patients with knee osteoarthritis: inter-rater reliability (ICC) met criteria for 11/12 sensation types, with “heaviness” being the most stable. The reliability of Deqi measurement tools is now sufficient to support experimental design.

Step 2: Deqi Corresponds to Observable Physiological and Neural Changes

Deqi involves not only subjective scales but also measurable physiological signals. PMID 25228908 directly posits that Deqi is essentially a threshold of stimulus intensity: following needle-induced Deqi, local blood perfusion at the acupoint, tissue displacement, and electromyographic amplitude all increase significantly, while fMRI shows signal increases or decreases across multiple brain regions. In other words, the subjective judgment of “presence or absence of Deqi” corresponds to an objective switch in acupoint and neural responses. PMID 27062952 further illustrates the neural basis of graded intensity: shallow needling at BL40 (2mm, inducing almost no Deqi) versus deep needling (10-20mm, inducing composite Deqi in 14/16 individuals) induced distinct alterations in resting-state brain networks. Deep needling with Deqi reduced connectivity between the Default Mode Network (DMN) and the pain matrix network while enhancing connections in the right posterior cerebellum, parahippocampal gyrus, thalamus, and supplementary motor area. Deqi shifts from a binary “yes/no” to a graded scale on the brain network level.

Step 3: Stimulus Intensity Does Exhibit Dose-Response—But the Direction Is Complex

If “dose” is operationalized as stimulus intensity, the direction of evidence is clear: stronger stimulation produces stronger modulation. PMID 31088511 was a multi-center three-arm RCT involving 301 patients with knee osteoarthritis: strong electrical acupuncture (>2mA) was significantly superior to weak electrical acupuncture (<0.5mA) and sham electrical acupuncture in pain relief and conditioned pain modulation (CPM). Strong electrical acupuncture improved CPM scores by an additional 9.73 points compared to weak electrical acupuncture (p<0.01). Similarly, PMID 16527396 found in a double-blind RCT with healthy individuals that high-intensity (up to tolerance but non-harmful) electrical acupuncture significantly increased pain thresholds, whereas low-intensity (strong but comfortable) and sham acupuncture showed no difference. These findings confirm a single-dose dose-response relationship between “stimulus intensity → physiological/clinical response.”

Step 4: But Evidence for “Subjective Deqi Intensity → Efficacy” Is Split

The critical reversal occurs when “dose” is operationalized as the patient-reported subjective intensity of Deqi; the dose-response relationship collapses. PMID 20964256 analyzed RCT data from 147 patients with osteoarthritis: Deqi intensity showed no significant correlation with pain relief (p=0.49), and patients with or without Deqi showed no difference in efficacy (p=0.52)—this is the most famous negative result regarding the relationship between Deqi and efficacy. Conversely, PMID 31223331 provides partial positive evidence: in patients with primary dysmenorrhea, the intensity, composition, and spread of Deqi sensations indeed influenced the immediate analgesic effect at the SP6 acupoint. One study negative, one positive; this dichotomy constitutes the core of the controversy.

Step 5: The Missing Puzzle Piece—Mediation Effects

Why does stimulus intensity exhibit a dose-response while subjective Deqi does not? The most plausible explanation is that a layer of “brain network modulation” lies between Deqi and efficacy, yet this mediation has never been systematically tested. PMID 24280949 demonstrated that in patients with chronic low back pain, abnormal DMN connectivity was reversed after 4 weeks of acupuncture, and the recovery of DMN connectivity was significantly correlated with pain relief. PMID 41520025 (2026, RCT with mediation analysis in fibromyalgia) directly performed mediation testing: electrical acupuncture mediated widespread pain relief by enhancing activation in the primary somatosensory cortex and S1-insular connectivity (“bottom-up” pathways), whereas sham laser followed a different “top-down” pathway. This proves the methodological feasibility of “brain network modulation mediating efficacy”—but no one has yet integrated “Deqi Intensity → Magnitude of Brain Network Modulation → Clinical Efficacy” into a single dose-response and mediation chain for measurement.

This is the empirical gap this paper aims to highlight: three independent lines of evidence each hold true (Deqi is quantifiable, Deqi corresponds to brain network changes, and brain network modulation mediates efficacy), but the complete causal chain connecting them has never been measured.

Evidence and Limitations

Verified: Deqi can be stably measured via standardized scales (PMID 17973984, 23935656); Deqi corresponds to changes in acupoint blood flow/electromyography/brain fMRI, with deep needling Deqi significantly altering DMN connectivity (PMID 25228908, 27062952); electrical acupuncture stimulus intensity exhibits a clear dose-response (PMID 31088511, 16527396); brain network changes induced by acupuncture correlate with clinical pain relief, and brain network modulation can mediate efficacy (PMID 24280949, 41520025).

Partially Verified: The relationship between subjective Deqi intensity and efficacy yields contradictory results—negative in osteoarthritis RCT (PMID 20964256) vs. positive in dysmenorrhea RCT (PMID 31223331)—suggesting potential influence from disease type, acupoint, or scale differences.

To Be Verified: The complete dose-response curve and mediation effects (Sobel/bootstrap mediation testing) of “Deqi Intensity Grading → Magnitude of Brain Network Modulation → Clinical Efficacy” have never been measured within the same longitudinal course; furthermore, whether subjective Deqi scales align with objective stimulus intensity scales lacks head-to-head validation.

Related Reading

Evidence Level: B (Deqi quantification, intensity dose-response, and brain network mediation of efficacy all have direct PubMed support; however, the complete mediation chain “Deqi Intensity → Network Modulation Magnitude → Efficacy” has no precedents and represents a research design proposal)
References: PMID 25228908, PMID 27062952, PMID 17973984, PMID 23935656, PMID 20964256, PMID 31223331, PMID 31088511, PMID 16527396, PMID 41520025, PMID 24280949


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *